Current Neuro-Oncology

Volume 8 Number 9
30 September 2006

Home > Publications > Current Neuro-Oncology > Volume 8, Year 2006 > Number 9, 30 September

Packer RJ, Gajjar A, Vezina G, Rorke-Adams L, Burger PC, Robertson PL, Bayer L, LaFond D, Donahue BR, Marymont MH, Muraszko K, Langston J, Sposto R.
Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.
J Clin Oncol. 2006 Sep 1;24(25):4202-8
. doi: 10.1200/JCO.2006.06.4980. PMID: 16943538. Phase 3 trial.

Gajjar A, Chintagumpala M, Ashley D, Kellie S, Kun LE, Merchant TE, Woo S, Wheeler G, Ahern V, Krasin MJ, Fouladi M, Broniscer A, Krance R, Hale GA, Stewart CF, Dauser R, Sanford RA, Fuller C, Lau C, Boyett JM, Wallace D, Gilbertson RJ.
Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.
Lancet Oncol. 2006 Sep 7;7(10):813-20
. doi: 10.1016/S1470-2045(06)70867-1. PMID: 17012043. Phase 2 trial.
Erratum in: Lancet Oncol. 2006 Oct;7(10):797. doi: 10.1016/S1470-2045(06)70881-6. Correction.